Clinical Trial Update: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rituximab in combination with methotrexate for rheumatoid arthritis patients with inadequate response to anti-TNF therapy; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MabThera (rituximab)
• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-11-04